Medullary Carcinomas of the Nonampullary Small Intestine: Association with Coeliac Disease, Mismatch Repair Deficiency, PD-L1 Expression, and Favourable Prognosis

Overview

Journal Histopathology

Specialties Anatomy & Histology
Pathology

Date 2024 Aug 28

PMID 39192803

Authors

Alessandro Vanoli

Federica Grillo

Giuseppe De Lisi

Camilla Guerini

Giovanni Arpa

Catherine Klersy

Matteo Fassan

Paola Parente

Luca Mastracci

Elena Biletta

Gabriella Nesi

Maria C Macciomei

Marco V Lenti

Erica Quaquarini

Anna M Chiaravalli

Daniela Furlan

Stefano La Rosa

Marco Paulli

Antonio Di Sabatino

Affiliations

Soon will be listed here.

Abstract

Aim: Gastrointestinal medullary carcinoma is a rare histologic subtype of adenocarcinoma. As nonampullary small bowel medullary carcinomas (SB-MCs) are poorly characterized, we aimed to analyse their clinicopathologic and immunohistochemical features and to compare them with nonmedullary small bowel adenocarcinomas (NM-SBAs).

Methods And Results: Surgically resected SBAs collected through the Small Bowel Cancer Italian Consortium were classified as SB-MCs (carcinomas with ≥50% of tumour fulfilling the typical histologic criteria of MC) or NM-SBAs. Immunohistochemistry for cytokeratin (CK)7, CK20, CDX2, programmed death-ligand 1 (PD-L1) and mismatch repair proteins was performed in both SB-MCs and NM-SBAs. SB-MCs were also tested for CK8/18, synaptophysin, SMARCB1, SMARCA2, SMARCA4, and ARID1A and for Epstein-Barr virus (EBV)-encoded RNAs by in-situ hybridization. MLH1 promoter methylation status was evaluated in MLH1-deficient cases. Eleven SB-MCs and 149 NM-SBAs were identified. One (9%) SB-MC was EBV-positive, while 10 (91%) harboured mismatch repair deficiency (dMMR). MLH1 promoter hypermethylation was found in all eight dMMR SB-MCs tested. Switch/sucrose nonfermentable deficiency was seen in two (18%) SB-MCs, both with isolated loss of ARID1A. Compared with NM-SBAs, SB-MCs exhibited an association with coeliac disease (P < 0.001), higher rates of dMMR (P < 0.001), and PD-L1 positivity by both tumour proportion score and combined positive score (P < 0.001 for both), and a lower rate of CK20 expression (P = 0.024). Survival analysis revealed a better prognosis of SB-MC patients compared to NM-SBA cases (P = 0.02).

Conclusion: SB-MCs represent a distinct histologic subtype, with peculiar features compared to NM-SBAs, including association with coeliac disease, dMMR, PD-L1 expression, and better prognosis.

References

Vanoli A, Di Sabatino A, Furlan D, Klersy C, Grillo F, Fiocca R . Small Bowel Carcinomas in Coeliac or Crohn's Disease: Clinico-pathological, Molecular, and Prognostic Features. A Study From the Small Bowel Cancer Italian Consortium. J Crohns Colitis. 2017; 11(8):942-953. DOI: 10.1093/ecco-jcc/jjx031. View

Thota R, Gonzalez R, Berlin J, Cardin D, Shi C . Could the PD-1 Pathway Be a Potential Target for Treating Small Intestinal Adenocarcinoma?. Am J Clin Pathol. 2017; 148(3):208-214. DOI: 10.1093/AJCP/AQX070. View

Ahadi M, Fuchs T, Clarkson A, Sheen A, Sioson L, Chou A . Switch/sucrose-non-fermentable (SWI/SNF) complex (SMARCA4, SMARCA2, INI1/SMARCB1)-deficient colorectal carcinomas are strongly associated with microsatellite instability: an incidence study in 4508 colorectal carcinomas. Histopathology. 2021; 80(6):906-921. DOI: 10.1111/his.14612. View

Vanoli A, Di Sabatino A, Martino M, Dallera E, Furlan D, Mescoli C . Epstein-Barr virus-positive ileal carcinomas associated with Crohn's disease. Virchows Arch. 2017; 471(4):549-552. DOI: 10.1007/s00428-017-2209-9. View

Jun S, Park E, Lee J, Chang H, Jung E, Oh Y . Prognostic Significance of Stromal and Intraepithelial Tumor-Infiltrating Lymphocytes in Small Intestinal Adenocarcinoma. Am J Clin Pathol. 2019; 153(1):105-118. DOI: 10.1093/ajcp/aqz136. View

Lee L, Cavalcanti M, Segal N, Hechtman J, Weiser M, Smith J . Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma. Mod Pathol. 2016; 29(11):1433-1442. PMC: 5083129. DOI: 10.1038/modpathol.2016.139. View

Gonzalez I, Goyal B, Xia M, Pai R, Ma C . DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma. Hum Pathol. 2018; 85:18-26. DOI: 10.1016/j.humpath.2018.10.013. View

Xue Y, Balci S, Pehlivanoglu B, Muraki T, Memis B, Saka B . Medullary carcinoma of the ampulla has distinct clinicopathologic characteristics including common association with microsatellite instability and PD-L1 expression. Hum Pathol. 2022; 131:38-46. DOI: 10.1016/j.humpath.2022.12.004. View

Chetty R . Gastrointestinal cancers accompanied by a dense lymphoid component: an overview with special reference to gastric and colonic medullary and lymphoepithelioma-like carcinomas. J Clin Pathol. 2012; 65(12):1062-5. DOI: 10.1136/jclinpath-2012-201067. View

10.

Giuffrida P, Arpa G, Grillo F, Klersy C, Sampietro G, Ardizzone S . PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability. Mod Pathol. 2020; 33(7):1398-1409. DOI: 10.1038/s41379-020-0497-0. View

11.

Remo A, Fassan M, Vanoli A, Reggiani Bonetti L, Barresi V, Tatangelo F . Morphology and Molecular Features of Rare Colorectal Carcinoma Histotypes. Cancers (Basel). 2019; 11(7). PMC: 6678907. DOI: 10.3390/cancers11071036. View

12.

Overman M, Pozadzides J, Kopetz S, Wen S, Abbruzzese J, Wolff R . Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine. Br J Cancer. 2009; 102(1):144-50. PMC: 2813754. DOI: 10.1038/sj.bjc.6605449. View

13.

Xue Y, Vanoli A, Balci S, Reid M, Saka B, Bagci P . Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas. Mod Pathol. 2016; 30(2):255-266. DOI: 10.1038/modpathol.2016.174. View

14.

Villatoro T, Ma C, Pai R . Switch/sucrose nonfermenting nucleosome complex-deficient colorectal carcinomas have distinct clinicopathologic features. Hum Pathol. 2020; 99:53-61. DOI: 10.1016/j.humpath.2020.03.009. View

15.

Pyo J, Sohn J, Kang G . Medullary carcinoma in the colorectum: a systematic review and meta-analysis. Hum Pathol. 2016; 53:91-6. DOI: 10.1016/j.humpath.2016.02.018. View

16.

Kim M, Gu M, Chang H, Yu E . Loss of ARID1A expression is associated with poor prognosis in small intestinal carcinoma. Histopathology. 2014; 66(4):508-16. DOI: 10.1111/his.12566. View

17.

Agaimy A . SWI/SNF-deficient Malignancies: Optimal Candidates for Immune-oncological Therapy?. Adv Anat Pathol. 2022; 30(3):211-217. DOI: 10.1097/PAP.0000000000000366. View

18.

Potter D, Murray J, Donohue J, Burgart L, Nagorney D, van Heerden J . The role of defective mismatch repair in small bowel adenocarcinoma in celiac disease. Cancer Res. 2004; 64(19):7073-7. DOI: 10.1158/0008-5472.CAN-04-1096. View

19.

Mastracci L, Grillo F, Parente P, Gullo I, Campora M, Angerilli V . PD-L1 evaluation in the gastrointestinal tract: from biological rationale to its clinical application. Pathologica. 2022; 114(5):352-364. PMC: 9614301. DOI: 10.32074/1591-951X-803. View

20.

Knox R, Luey N, Sioson L, Kedziora A, Clarkson A, Watson N . Medullary colorectal carcinoma revisited: a clinical and pathological study of 102 cases. Ann Surg Oncol. 2015; 22(9):2988-96. DOI: 10.1245/s10434-014-4355-5. View